Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01344187 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Phase 3 study of Keratoconus, sponsored by Glaukos Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 236
- Enrollment target
- 10
- Study locations
NCT01344187: Completed Phase 3 study of Keratoconus, sponsored by Glaukos Corporation.
NCT01344187 is a Phase 3 study of Keratoconus that has completed, run by Glaukos Corporation. The registered enrollment target is 236 participants, below the 1,169-participant average among 21 other Keratoconus trials with a reported enrollment target (80% lower). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01344187, a Phase 3 study of Keratoconus, has completed, sponsored by Glaukos Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 236 participants
- Enrollment target
- 10
- Study locations
Study Summary
The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.
Conditions Studied
Interventions
- DRUG riboflavin solution
- DRUG placebo solution
- DEVICE KXL System
Study Locations (10)
California
- UC Irvine Department of Ophthalmology - Irvine
Florida
- Bascolm Palmer Eye Institute - Miami
Georgia
- Emory Eye Center - Atlanta
Massachusetts
- Ophthalmic Consultants of Boston - Waltham
Nebraska
- Kugler Vision - Omaha
New Jersey
- Pinceton Eye Goup - Princeton
Ohio
- Comprehensive Eye Care of Central Ohio - Westerville
South Carolina
- Medical University of South Carolina Storm Eye Institute, Magill Vision Center - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-06 |
| Phase | Phase 3 |
What the finished NCT01344187 record still lists
NCT01344187 is an interventional study that assigns participants to a tested intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap, below the 1,169-participant average among 21 other Keratoconus trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Keratoconus appearing as the primary indexed condition, and to 3 interventions - of which riboflavin solution is the first listed.
NCT01344187 lists 10 locations in 10 states (California, Florida, Georgia).
Frequently Asked Questions
What is clinical trial NCT01344187 about?
NCT01344187 is a clinical study titled "Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus". The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.
What is the current status of trial NCT01344187?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 236 participants. The study started on 2012-07. Estimated completion is 2016-06.
What conditions does trial NCT01344187 study?
This clinical trial studies the following conditions: Keratoconus.
What interventions are being tested in trial NCT01344187?
The interventions under investigation include: riboflavin solution (DRUG), placebo solution (DRUG), KXL System (DEVICE).
Who is sponsoring clinical trial NCT01344187?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01344187 being conducted?
This trial has 10 study locations across California, Florida, Georgia, Massachusetts, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01344187's enrollment target sits among peer trials
236 11th of 21 higher than 11 of 21 other Keratoconus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Keratoconus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
RECRUITING · Phase 3
-
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
RECRUITING · Phase 3
-
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus
ACTIVE NOT RECRUITING · Phase 3
-
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
OCT in Diagnosis of Irregular Corneas
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04995341 · 236 participants · NA
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
- NCT05822362 · 236 participants · Phase 2
CBD for Individuals at Risk for Alzheimer's Disease
- NCT06200103 · 236 participants · Phase 2
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- NCT06494072 · 236 participants · Phase 4
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia